ESTABLISHING COVERAGE AGAINST RESPIRATORY SYNCYTIAL VIRUS (RSV) IN YOUNG CHILDREN
New for 2021! EIP are pleased to confirm that a second new vaccine-specific Working Group will be added to the line-up in 2021. The Respiratory Syncytial Virus (RSV) Vaccines Working Group has been convened to review and advise on the best strategies for avoiding the unnecessary hospitalisation of under 5s by the use of RSV vaccinations across Europe. This new area has the potential to significantly cut the number of hospitalisations per year (estimated two be 30,000 in the UK alone), but we must decide on the most successful strategy to establish RSV vaccinations in vaccine schedules over the coming years.
If you wish to participate nominate yourself or your organisation